Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

2321.85 (Glytoucan)

Id:aa6730ad-f8c9-56b7-a280-a42d6eaf62b2

Glytoucan:G20285AX

Results found

Linked to

	Label	Description
	2321.85 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000005 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2321.85 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000001 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2321.85 has canonical residue n-glycan b-d-glcpnac 7 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2321.85 has glycosequence GLYGEN.GLYCOSEQUENCE:G17028OG-GLYCOSEQ00115327 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2321.85 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000021 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2321.85 has glycosequence GLYGEN.GLYCOSEQUENCE:G00709CF-GLYCOSEQ00008961 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2321.85 has glycosequence GLYGEN.GLYCOSEQUENCE:G52362GH-GLYCOSEQ00146060 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2321.85 has canonical residue n-glycan core d-glcnac a Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2321.85 has glycosequence GLYGEN.GLYCOSEQUENCE:G51253QV-GLYCOSEQ00047276 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2321.85 has glycosequence GLYGEN.GLYCOSEQUENCE:G79412GP-GLYCOSEQ00176049 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2321.85 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000005 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2321.85 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000001 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2321.85 has canonical residue n-glycan b-d-glcpnac 7

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2321.85 has glycosequence GLYGEN.GLYCOSEQUENCE:G17028OG-GLYCOSEQ00115327 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2321.85 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000021 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2321.85 has glycosequence GLYGEN.GLYCOSEQUENCE:G00709CF-GLYCOSEQ00008961 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2321.85 has glycosequence GLYGEN.GLYCOSEQUENCE:G52362GH-GLYCOSEQ00146060 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2321.85 has canonical residue n-glycan core d-glcnac a

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2321.85 has glycosequence GLYGEN.GLYCOSEQUENCE:G51253QV-GLYCOSEQ00047276 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2321.85 has glycosequence GLYGEN.GLYCOSEQUENCE:G79412GP-GLYCOSEQ00176049 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.